Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$8.48 - $11.13 $1.05 Million - $1.38 Million
-123,838 Reduced 31.96%
263,661 $2.25 Million
Q2 2022

Aug 11, 2022

BUY
$9.95 - $12.27 $2.97 Million - $3.66 Million
298,330 Added 334.57%
387,499 $4.06 Million
Q1 2022

May 12, 2022

SELL
$9.81 - $15.4 $987,572 - $1.55 Million
-100,670 Reduced 53.03%
89,169 $970,000
Q4 2021

Feb 09, 2022

BUY
$12.09 - $14.68 $682,468 - $828,671
56,449 Added 42.32%
189,839 $2.57 Million
Q3 2021

Nov 10, 2021

SELL
$13.25 - $15.13 $552,087 - $630,421
-41,667 Reduced 23.8%
133,390 $1.81 Million
Q2 2021

Aug 12, 2021

SELL
$12.97 - $16.15 $1.07 Million - $1.33 Million
-82,315 Reduced 31.98%
175,057 $2.5 Million
Q1 2021

May 13, 2021

BUY
$13.59 - $18.54 $3.26 Million - $4.44 Million
239,572 Added 1345.91%
257,372 $3.6 Million
Q4 2020

Feb 12, 2021

BUY
$14.3 - $18.74 $254,540 - $333,572
17,800 New
17,800 $334,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Alpha Crest Capital Management LLC Portfolio

Follow Alpha Crest Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Crest Capital Management LLC with notifications on news.